About HIGH CARE pharma
HIGH CARE pharma is a Healthcare company based in Mumbai (India) founded in 2017. It produces high-quality pharmaceutical products including tablets, capsules, syrup, and semi-solids. It operates on a B2B model. Its Indian entity High Care Pharma Private Limited reported revenue of ₹3.7 Lakh. Its focus areas include Pharmaceuticals, Drug Manufacturing and Tablets and Capsules. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
HIGH CARE pharma, established in 2017, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and tablets and capsules. Produces high-quality pharmaceutical products including tablets, capsules, syrup, and semi-solids. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website highcarepharma.com
- Legal Name High Care Pharma Private Limited
- Date of Incorporation 23 Feb, 2015
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.7 Lakh
FY 2025 · -86% YoY
- Net Profit₹71,143
FY 2025 · 19% margin
- EBITDA₹86,401
FY 2025 · 24% margin
Associated legal entities of HIGH CARE pharma
HIGH CARE pharma operates through High Care Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| High Care Pharma Private Limited CIN U24233TG2015PTC097738 | Active | 23 Feb 2015 | Hyderabad, Telangana | ₹0.0 Cr | 3 | View details |
Board of directors of High Care Pharma Private Limited (HIGH CARE pharma)
High Care Pharma Private Limited is the primary company behind HIGH CARE pharma. The board of High Care Pharma Private Limited currently have 3 directors; the longest-serving is Kumar Hari Kiran Karanam, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kumar Hari Kiran Karanam DIN 07074261 | Director | 23 Feb 2015 | 11 yrs 7 mo | High Care Pharma Private Limited |
| John Shaheed Shaik DIN 07288306 | Director | 16 Sep 2015 | 11 yrs 1 mo | High Care Pharma Private Limited |
| Mustafa Shaik DIN 09291310 | Director | 24 Aug 2021 | 5 yrs 2 mo | High Care Pharma Private Limited |
Financials of HIGH CARE pharma
Figures of High Care Pharma Private Limited, the primary company behind HIGH CARE pharma, for FY 2025. Revenue was ₹3.7 Lakh (-86% year on year). Net profit was ₹71,143 (19% margin). EBITDA was ₹86,401 (24% margin). Revenue has grown at a compounded annual rate of -44% over three years and -42% over five years.
- ₹3.7 LakhRevenue · FY 2025 · -86% YoY
- ₹71,143Net profit · 19% margin
- ₹86,401EBITDA · 24% margin
- ₹1.00 CrPaid-up capital
- -44%Revenue CAGR, 3 years
- -42%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of High Care Pharma Private Limited are on its company page.
Detailed financial statements for HIGH CARE pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to HIGH CARE pharma
HIGH CARE pharma has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of HIGH CARE pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HIGH CARE pharma
HIGH CARE pharma was founded in 2017.
HIGH CARE pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind HIGH CARE pharma, High Care Pharma Private Limited, reported revenue of ₹3.7 Lakh for FY 2025, down 86% year on year.
HIGH CARE pharma, established in 2017, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and tablets and capsules. Produces high-quality pharmaceutical products including tablets, capsules, syrup, and semi-solids. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
HIGH CARE pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
HIGH CARE pharma operates through High Care Pharma Private Limited.
The legal entities of HIGH CARE pharma currently have 3 directors, including Mustafa Shaik, John Shaheed Shaik, Kumar Hari Kiran Karanam.